Exploring Three High Growth Tech Stocks in the United States

Simply Wall St.11-16

The United States market has been flat in the last week yet it is up 32% over the past year with earnings forecast to grow by 15% annually. In this context, identifying high growth tech stocks that ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2483832385?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305","is_english":true,"pubTime":"2024-11-16 02:07","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2483832385","market":"us","top_or_hot":-1,"title":"Exploring Three High Growth Tech Stocks in the United States","media":"Simply Wall St.","content":"<div>\n<p>The United States market has been flat in the last week yet it is up 32% over the past year with earnings forecast to grow by 15% annually. In this context, identifying high growth tech stocks that ...</p>\n\n<a href=\"https://finance.yahoo.com/news/exploring-three-high-growth-tech-180723101.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Exploring Three High Growth Tech Stocks in the United States</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nExploring Three High Growth Tech Stocks in the United States\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-16 02:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/exploring-three-high-growth-tech-180723101.html><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The United States market has been flat in the last week yet it is up 32% over the past year with earnings forecast to grow by 15% annually. In this context, identifying high growth tech stocks that ...</p>\n\n<a href=\"https://finance.yahoo.com/news/exploring-three-high-growth-tech-180723101.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4554","symbol_name":"元宇宙及AR概念","start_time":0,"source_url":"https://finance.yahoo.com/news/exploring-three-high-growth-tech-180723101.html","article_id":"2483832385","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483832385","pubTimestamp":1731694043,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"The United States market has been flat in the last week yet it is up 32% over the past year with earnings forecast to grow by 15% annually. In this context, identifying high growth tech stocks that align with these robust market conditions can be crucial for investors looking to capitalize on potential opportunities.Top 10 High Growth Tech Companies In The United States. Click here to see the full list of 244 stocks from our US High Growth Tech and AI Stocks screener.Overview: Travere Therapeutics, Inc. is a biopharmaceutical company focused on identifying, developing, and delivering therapies for rare kidney and metabolic diseases, with a market cap of $1.62 billion.Take a closer look at Travere Therapeutics' potential here in our health report.Gain insights into Travere Therapeutics' past trends and performance with our Past report.Overview: Autodesk, Inc. is a global provider of 3D design, engineering, and entertainment technology solutions with a market capitalization of $67.34 bil","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4554":"元宇宙及AR概念","IE00B894F039.SGD":"Legg Mason ClearBridge - US Aggressive Growth A Acc SGD-H","LU1429558221.USD":"Natixis Loomis Sayles US Growth Equity RA USD","LU2238339852.HKD":"NINETY ONE GSF GLOBAL ENVIRONMENT \"A\" (HKD) ACC","LU2247934214.USD":"FIDELITY FUNDS SUSTAINABLE FUTURE CONNECTIVITY \"A\" (USD) ACC","LU1435385759.SGD":"Natixis Loomis Sayles US Growth Equity RA SGD-H","LU1983260115.SGD":"Janus Henderson Horizon Global Sustainable Equity A2 SGD-H","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","LU0426412945.USD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (USD) ACC","LU1823568750.SGD":"Fidelity Global Technology A-ACC SGD","LU1043141396.HKD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (HKD) ACC","LU1992135399.USD":"Allianz Global Intelligent Cities AT Acc USD","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","BK4211":"区域性银行","BK4566":"资本集团","LU2272731782.SGD":"Allianz Global Intelligent Cities AM Dis H2-SGD","LU2272731600.USD":"Allianz Global Intelligent Cities AM Dis USD","LU0345774631.USD":"NINETY ONE GSF AMERICAN FRANCHISE \"A\" (USD) INC","IE00B19Z9P08.USD":"LEGG MASON CLEARBRIDGE US AGGRESSIVE GROWTH \"A\" (USD) INC","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","LU1043141123.HKD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (HKD) INC 2","LU1992135472.HKD":"ALLIANZ GLOBAL INTELLIGENT CITIES \"AT\" (HKD) ACC","ADSK":"欧特克","IE00B19Z9Z06.USD":"Legg Mason ClearBridge - US Aggressive Growth A Acc USD","BK4588":"碎股","IE00BZ9MQY76.HKD":"FTGF CLEARBRIDGE US AGGRESSIVE GROWTH \"A\" (HKD) ACC","RIGL":"Rigel Pharmaceuticals","LU0994945656.USD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (USD) INC 2","LU2326559502.SGD":"Natixis Loomis Sayles US Growth Equity P/A SGD-H","LU1721428933.USD":"法巴全球经典环境基金RH MD Dis","LU0426417589.USD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (USD) INC","LU1046421795.USD":"富达环球科技A-ACC","LU1691799644.USD":"Amundi Funds Polen Capital Global Growth A2 (C) USD","LU2298064838.USD":"NINETY ONE GSF GLOBAL ENVIRONMENT \"A\" (USD) INC","BK4023":"应用软件","LU1235294995.USD":"FIDELITY GLOBAL TECHNOLOGY \"A\" (USDHDG) ACC","LU1939255532.USD":"NINETY ONE GSF GLOBAL ENVIRONMENT \"A\" (USD) ACC","BK4528":"SaaS概念","LU0345774391.USD":"NINETY ONE GSF AMERICAN FRANCHISE \"A\" (USD) ACC","UBCP":"联合合众银行","LU0323240290.USD":"HSBC GIF GLOBAL EQUITY CLIMATE CHANGE \"AD\" INC","TVTX":"Travere Therapeutics, Inc.","LU1121112475.USD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (USDHDG) ACC"},"translate_title":"探索美国三只高增长科技股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"UBCP":1,"ADSK":0.9,"RIGL":0.9,"TVTX":0.9},"content_text":"The United States market has been flat in the last week yet it is up 32% over the past year with earnings forecast to grow by 15% annually. In this context, identifying high growth tech stocks that align with these robust market conditions can be crucial for investors looking to capitalize on potential opportunities.\nTop 10 High Growth Tech Companies In The United States\n\n\n\nName\nRevenue Growth\nEarnings Growth\nGrowth Rating\n\n\nSarepta Therapeutics\n23.89%\n42.65%\n★★★★★★\n\n\nInvivyd\n47.87%\n67.72%\n★★★★★★\n\n\nAlkami Technology\n21.89%\n98.60%\n★★★★★★\n\n\nTG Therapeutics\n34.66%\n56.48%\n★★★★★★\n\n\nAlnylam Pharmaceuticals\n22.45%\n70.66%\n★★★★★★\n\n\nLegend Biotech\n34.07%\n69.26%\n★★★★★★\n\n\nBlueprint Medicines\n25.27%\n68.62%\n★★★★★★\n\n\nTravere Therapeutics\n31.19%\n72.58%\n★★★★★★\n\n\nSeagen\n22.57%\n71.80%\n★★★★★★\n\n\nImmunoGen\n26.00%\n45.85%\n★★★★★★\n\n\n\nClick here to see the full list of 244 stocks from our US High Growth Tech and AI Stocks screener.\nLet's review some notable picks from our screened stocks.\nTravere Therapeutics\nSimply Wall St Growth Rating: ★★★★★★\nOverview: Travere Therapeutics, Inc. is a biopharmaceutical company focused on identifying, developing, and delivering therapies for rare kidney and metabolic diseases, with a market cap of $1.62 billion.\nOperations: The company generates revenue primarily through the development and commercialization of innovative therapies, amounting to $203.45 million. Its focus is on addressing rare kidney and metabolic diseases.\nTravere Therapeutics, recently engaging in multiple equity offerings, including a significant $125 million raise, reflects a strategic push to bolster its financial runway amidst challenging profitability metrics. The company's revenue surged by 69% year-over-year to $62.9 million in Q3 2024, yet it reported a substantial net loss of $54.81 million for the same period. This juxtaposition highlights aggressive investment in R&D and market expansion despite short-term earnings volatility. Notably, Travere's commitment to innovation is evident as R&D expenses have escalated in alignment with its pursuit of breakthrough therapies in nephrology and rare diseases—sectors demanding high investment for long-term gains. With recent FDA approvals boosting its commercial portfolio and a clear focus on scaling up promising treatments like FILSPARI®, Travere is navigating through its growth phase with calculated financial maneuvers and clinical advancements.\n\nTake a closer look at Travere Therapeutics' potential here in our health report.\nGain insights into Travere Therapeutics' past trends and performance with our Past report.\n\n\n\n\n  NasdaqGM:TVTX Earnings and Revenue Growth as at Nov 2024\n \n\nAutodesk\nSimply Wall St Growth Rating: ★★★★☆☆\nOverview: Autodesk, Inc. is a global provider of 3D design, engineering, and entertainment technology solutions with a market capitalization of $67.34 billion.\nOperations: Autodesk generates revenue primarily from its CAD/CAM software segment, which contributed $5.81 billion. The company's business model focuses on providing advanced design and engineering solutions across various industries worldwide.\nAutodesk's strategic collaborations, notably with Trane Technologies and Esri, underscore its commitment to integrating AI and geospatial data into design processes, enhancing sustainability in building and planning sectors. This focus on innovation is mirrored in its R&D spending, which remains robust at 15.7% of revenue, aligning with industry demands for advanced software solutions. Financially, Autodesk has shown resilience with a 10% annual revenue growth forecast and an anticipated earnings increase of 15.73% per year, reflecting its adaptability in a competitive landscape. These initiatives not only strengthen Autodesk’s market position but also promise to drive future industry standards in design technology.\n\nNavigate through the intricacies of Autodesk with our comprehensive health report here.\nGain insights into Autodesk's historical performance by reviewing our past performance report.\n\n\n\n\n  NasdaqGS:ADSK Earnings and Revenue Growth as at Nov 2024\n \n\nRigel Pharmaceuticals\nSimply Wall St Growth Rating: ★★★★★☆\nOverview: Rigel Pharmaceuticals, Inc. is a biotechnology company focused on discovering, developing, and providing therapies for hematologic disorders and cancer, with a market cap of $482.83 million.\nOperations: Rigel Pharmaceuticals generates revenue primarily from its biotechnology segment, amounting to $157.37 million. The company focuses on developing therapies for hematologic disorders and cancer.\nRigel Pharmaceuticals has demonstrated a remarkable turnaround, evidenced by its recent earnings report where Q3 revenue soared to $55.31 million from $28.13 million year-over-year, alongside a shift to a net income of $12.42 million from a previous net loss of $5.69 million. This financial revival is underpinned by aggressive R&D efforts which are integral to its strategy, focusing on expanding its hematology-oncology portfolio as seen with six upcoming presentations at the ASH Annual Meeting. The company's commitment to innovation is further highlighted by an R&D expenditure that aligns with its revenue growth forecast of 12.8% annually, significantly outpacing the industry standard.\n\nDelve into the full analysis health report here for a deeper understanding of Rigel Pharmaceuticals.\nExamine Rigel Pharmaceuticals' past performance report to understand how it has performed in the past.\n\n\n\n\n  NasdaqGS:RIGL Revenue and Expenses Breakdown as at Nov 2024\n \n\nKey Takeaways\n\nClick through to start exploring the rest of the 241 US High Growth Tech and AI Stocks now.\nInvested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.\nSimply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.\n\nCurious About Other Options?\n\nExplore high-performing small cap companies that haven't yet garnered significant analyst attention.\nFuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.\nFind companies with promising cash flow potential yet trading below their fair value.\n\n This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.\nCompanies discussed in this article include NasdaqGM:TVTX NasdaqGS:ADSK and NasdaqGS:RIGL.\nHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2483832385"}